kras mutation and glutathion Frontiers Promising direction for the treatment
Promising direction for the treatment of pancreatic cancers driven by KRAS mutation Der Lab Targeting KRAS mutant stomach colorectal tumors by disrupting the ERK2 p53 complex ScienceDirect kras mutation and glutathion glynac Glutathione Depletion Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Isoform Specific Destabilization of the Active Impact of KRAS mutation on the tumor microenvironment in colorectal cancer
Pay in 4 interest-free payments of $6.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19



